- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Eleanor Perfetto Explains Concerns With Using QALY as Basis for Coverage Decisions
Given the limitations of the quality-adjusted life year (QALY) measure, Eleanor M. Perfetto, PhD, MS, senior vice president of Strategic Initiatives for the National Health Council, outlines concerns with using the measure as the basis for coverage decisions.
Given the limitations of the quality-adjusted life year (QALY) measure, Eleanor M. Perfetto, PhD, MS, senior vice president of Strategic Initiatives for the National Health Council, outlines concerns with using the measure as the basis for coverage decisions.
Transcript
Given the limitations of the quality-adjusted life year, what concerns are there with using the measure for the basis of coverage decisions?
It’s really important that people understand that the QALY [quality-adjusted life year] or a QALY measure that might come out of an assessment of some kind, a health technology assessment or a value assessment, that it’s just one piece of information that a decision maker might take into account, and that it shouldn’t be the only thing they base their decision on. That’s a real concern to the patient community, that it not be the sole basis for decision making, especially with all the limitations that we know the QALY has.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
